Design and modeling of new platelet-activating factor antagonists.3. Relative importance of hydrophobicity and electronic distribution in piperazinic series
Dive, Georges ; Université de Liège - ULiège > Centre d'ingénierie des protéines
Lamouri, Aazdine
Bellahsene, Tounès
Touboul Estéra
Huet, Jack
Tavet, Fabrice
Redeuilh, Catherine
Godfroid, Jean-Jacques
Language :
English
Title :
Design and modeling of new platelet-activating factor antagonists.3. Relative importance of hydrophobicity and electronic distribution in piperazinic series
Batt, J.-P., Lamouri, A., Tavet, F., Heymans, F., Dive, G. and Godfroid, J.-J. (1991) New hypothesis on the conformation of the PAF-receptor from studies on the geometry of selected platelet-activating factor-antagonists. J. Lipid Mediators 4, 343-346.
Dehareng, D., Dive, G. and Ghuysen, J.M. (1993) Polarization-corrected electrostatic potentials of aromatic compounds. J. Am. Chem. Soc. 115, 6877-6882.
Dewar, M.J.S., Zoebisch, E.G., Hearly, E.F. and Stewart J.J.P. (1985) A new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 107, 3902-3909.
Dive, G. and Dehareng, D. (1993) Polarization correction of the electrostatic potential for aromatic compounds: study of the nucleophilic attack. Int. J. Quantum Chem. 46, 127-136.
Frish, M.J., Trucks, G.W., Head-Gordon, M. et al. (1992) GAUSSIAN 92, Unix revision B, Gaussian, Inc., Carnegie-Mellon Quantum Chemistry Publishing Unit, Carnegie-Mellon University, Pittsburgh, PA 15213.
Giessner-Prettre, C. and Pullman, A. (1972) Molecular electrostatic potentials: comparison between ab initio and CNDO results. Theor. Chim. Acta (Berlin) 25, 83-88.
Godfroid, J.J., Broquet, C., Jouquey, S. et al. (1987) Structure-activity relationship in PAF-acether. 3. Hydrophobic contribution to agonistic activity. J. Med. Chem. 30, 792-797.
Hodgkin, E.E., Miller, A. and Whittaker, M. (1992) A partial pharmacophore for the platelet activating factor (PAF) receptor. Bioorg. Med. Chem. Lett. 2, 597-602.
Hodgkin, E.E., Miller, A. and Whittaker, M. (1993) A Monte Carlo pharmacophore generation procedure: Application to the human PAF receptor. J. Comput.-Aided Mol. Des. 7, 515-534.
Koltai, M., Guinot, P., Hosford, D. and Braquet, P. (1994) Platelet-activating factor antagonists; scientific background and possible clinical applications. Adv. Pharmacol. 28, 81-167.
Kubinyi, H. (1976) Quantitative structure-activity relationships. IV-Non-linear dependence of biological activity on hydrophobic character: a new model. Arzneim. Forsch. 26, 1991-1997.
Kubinyi, H. (1977) Quantitative structure-activity relationships. 7. The bilinear model, a new model for nonlinear dependence of biological activity on hydrophobic character. J. Med. Chem. 20, 625-629.
Lamouri, A., Heymans, F., Tavet, F. et al. (1993) Design and modeling of new platelet-activating factor antagonists. 1. Synthesis and biological activity of 1,4-bis-(3′,4′,5′-trimethoxybenzoyl)-2-[[(substituted carbonyl and carbamoyl)oxy]methyl]-piperazines. J. Med. Chem. 36, 990-1000.
Rekker, R.F. and De Koort, M.M. (1979) The Hydrophobic fragmental constant; extension to a 1000 data point set.Eur. J. Med. Chem.-Chim. Ther. 14, 479-488.
Stensland, B., Batt, J.-P., Lamouri, A. and Godfroid, J.-J. (1993) Platelet-activating factor. Structure of N,N′-bis (3,4,5-trimethoxybenzoyl-2-Piperazinylmethyl 2,2-dimethylpropanoate. Acta Crystallogr. C47, 1453-1457.
Tatewaki, H. and Huzinaga, S. (1980) A systematic preparation of new contracted Gaussian-type orbital sets. III. Second-row atoms from Li through Ne. J. Comp. Chem. 1, 205-228.
Tavet, F., Lamouri A., Heymans, F. et al. (1996) Design and modeling of new platelet-activating factor antagonists. 2. Synthesis and biological activity of 1,4-bis-(3′,4′,5′-trimethoxybenzoyl)-2-alkyl and 2-alkyloxymethylpiperazines. J. Lip. Mediators, 15 (1996) 145-159.
Toldy, L., Toth, I. and Borsy, J. (1966) Derivatives of piperazine. I. Derivatives of 3,4,5-trimethoxybenzoyl piperazine, a new group of compounds with antiulcerogenic activity. Acta Chim. Acad. Sci. Hung. 46, 265-286.
